Key facts
- This page summarizes Samuel N. Hazen's Form 4 filing for HCA Healthcare, Inc. (HCA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Feb 2026, 18:45.
Samuel N. Hazen - 10 Feb 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)
- Reporting relationship
- CEO, Director
- Issuer ticker
- HCA
- Reported as of
- 10 Feb 2026
- Net transaction value
- -$10,705,212
- SEC form
- 4
- Accepted by SEC
- 12 Feb 2026, 18:45:03 UTC
- Prior SEC filing
- 05 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin A. Ball, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Samuel N. Hazen filed Form 4 for HCA Healthcare, Inc. (HCA) on 12 Feb 2026.
Change
- Previous filing in this sequence was filed on 05 Feb 2026.
- Current net transaction value: -$10,705,212.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001216838
Primary reporting owner
HAZEN SAMUEL N
- Relationship
- CEO, Director
- Address
- ONE PARK PLAZA, NASHVILLE
- Signature
- /s/ Kevin A. Ball, Attorney-in-Fact
- Signature date
- 12 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HCA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +54,934
- Change %
- +176%
- Price
- $0.000000
- Shares after
- 86,165
- Date
- 10 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
HCA
transaction
Common Stock
Tax liability
- Transaction value
- $10,705,212
- Shares
- -21,323
- Change %
- -25%
- Price
- $502.05
- Shares after
- 64,842
- Date
- 10 Feb 2026
- Ownership
- Direct
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,024
- Date
- 10 Feb 2026
- Ownership
- By HD Trust
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16,731
- Date
- 10 Feb 2026
- Ownership
- By 2023 GST Trust
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 93,088
- Date
- 10 Feb 2026
- Ownership
- By 2023 Trust
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 178,289
- Date
- 10 Feb 2026
- Ownership
- By 2024 GRAT
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 200,000
- Date
- 10 Feb 2026
- Ownership
- By 2025 GRAT
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 813,320
- Date
- 10 Feb 2026
- Ownership
- By LP
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.